Risk assessment: Situation in northern Africa/Libyan Arab Jamahiriya and the influx of migrants* to Europe
ECDC, after conducting rapid risk assessments, has concluded that the risk of importation of infectious diseases from North Africa to the EU is considered to be low. From a public health perspective, the most urgent concern is related to the poor living conditions of the migrants, such as overcrowding and poor sanitation.
Rapid risk assessment: A(H5N1) Highly Pathogenic Avian Influenza in Egypt – Implications for human health in Europe
Highly pathogenic avian influenza A(H5N1) infections are continuing to occur in poultry and humans in Egypt. However there is no evidence of a significant change in the pattern of human illness and deaths related to A(H5N1) virus infections in the country. Certainly there are no epidemiological data or analyses consistent with adaptation of these viruses to humans.
Rapid risk assessment: Transmission of Foot and Mouth disease to humans visiting affected areas
The risk of Foot and Mouth disease being transmitted to humans visiting affected areas is extremely low, if consumption of pasteurised milk, dairy products or unprocessed meat from infected animals and direct contact with such animals is avoided.
Outbreak of measles in Ukraine and potential for spread in the EU, 2012
A rapid risk assement on the risk of measles for visitors to Ukraine, particularly during the UEFA European Football Championship, EURO 2012, and the potential spread of infection within the EU.
Communicable disease threats report, 14-20 October 2012, week 42
The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control.
Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
Outbreak of hepatitis A virus infection in travellers returning from Egypt
Between 1 November 2012 and 30 April 2013, 15 confirmed cases of hepatitis A virus infections with subgenotype IB and identical RNA sequence, and 89 probable cases, have been reported in 14 EU/EFTA countries. All cases have a travel history to Egypt.
Risk assessment: Wild-type poliovirus 1 transmission in Israel – what is the risk to Europe?
The EU/EEA countries and the rest of the WHO European Region, have been officially polio-free since 2002. However, wild-type polio virus 1 (WPV1) has been isolated in sewage and in the faeces of asymptomatic carriers in Israel since February 2013. In this risk assessment ECDC looks at the potential impact of this public health event on the risk of poliovirus being imported and re-established into circulation in EU/EEA.
Suspected outbreak of poliomyelitis in Syria: Risk of importation and spread of poliovirus in the EU
Following the announcement by WHO of a cluster of cases of acute flaccid paralysis in Syria, ECDC conducted a risk assessment and concludes that this does pose a risk that polio might be imported to the EU. The Risk Assessment includes number of recommendations for EU Member States.
Communicable disease threats report, 27 October - 2 November 2013, week 44
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 October - 2 November 2017, and includes updates on botulism, cholera, dengue, influenza, MERS, polio and West Nile fever.